DOES DISCORDANCE BETWEEN BASELINE PATIENT’S AND EVALUATOR’S GLOBAL ASSESSMENT OF DISEASE ACTIVITY IMPACT RETENTION AND REMISSION RATES OF TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS?:DATA FROM THE EUROSPA RESEARCH COLLABORATION

Details

Database :

OAIster

Journal :

Michelsen , B , Ørnbjerg , L , Mann , H , Sexton , J , Nissen , M , Santos , M J , Nordström , D , Jacobsson , L T H , Rotar , Z , Gudbjornsson , B , Koca , S S , Codreanu , C , Pombo-suarez , M , Horst-bruinsma , I V D , Loft , A G , Pavelka , K , Kristianslund , E , Moeller , B , Vieira-sousa , E , Hokkanen , A , Lindström , U , Tomsic , M , Love , T J , Goker , B , Ionescu , R , Sánchez-piedra , C , Sande , M V D , Macfarlane , G , Iannone , F , Hyldstrup , L , Krogh , N S , Østergaard , M & Hetland , M L 2019 , ' DOES DISCORDANCE BETWEEN BASELINE PATIENT’S AND EVALUATOR’S GLOBAL ASSESSMENT OF DISEASE ACTIVITY IMPACT RETENTION AND REMISSION RATES OF TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS? DATA FROM THE EUROSPA RESEARCH COLLABORATION ' , Annals of the Rheumatic Diseases , vol. 78 , no. Suppl 2 , FRI0453 , pp. 919-919 .

Notes :

English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1322740977

Document Type :

Electronic Resource